Alternating Thalidomide and Lenalidomide Therapy Plus Rituximab (ThRiL) as Initial Treatment for Patients With CLL
Clinical trial NCT01125176 · COMPLETED
Trial details
- NCT number
- NCT01125176
- Sponsor
- Weill Medical College of Cornell University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-30
- Primary completion
- 2018-12-20
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.